STOCK TITAN
  1. Home
  2. Sec-filings
  3. BNTX
  4. [6-K] BioNTech SE American Depositary Share Current Report (Foreign Issuer)

[6-K] BioNTech SE American Depositary Share Current Report (Foreign Issuer)

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
6-K
Rhea-AI Filing Summary
Analyzing...
Positive
  • None.
Negative
  • None.

Filing content is currently unavailable.

Source: View Original Filing on SEC EDGAR

Stock BNTX logo
BIONTECH

NASDAQ:BNTX

BNTX Rankings

#666 Ranked by Market Cap
N/A Ranked by Dividends

BNTX Latest News

Aug 4, 2025
BioNTech Announces Second Quarter 2025 Financial Results and Corporate Update
Jul 25, 2025
Pfizer and BioNTech Receive Positive CHMP Opinion for LP.8.1-Adapted COVID-19 Vaccine in the European Union
Jul 21, 2025
BioNTech to Report Second Quarter 2025 Financial Results and Corporate Update on August 4, 2025
Jul 17, 2025
BioNTech Announces Ryan Richardson to Step Down from the Management Board
Jun 25, 2025
Political polarisation is rising globally and posing new challenges for businesses, according to Willis latest report

BNTX Latest SEC Filings

Aug 4, 2025
[6-K] BioNTech SE American Depositary Share Current Report (Foreign Issuer)
Aug 4, 2025
[6-K] BioNTech SE American Depositary Share Current Report (Foreign Issuer)
Jul 25, 2025
[6-K] BioNTech SE American Depositary Share Current Report (Foreign Issuer)

BNTX Stock Data

25.80B
89.69M
62.69%
22.4%
2.51%
Biotechnology
Healthcare
Link
Germany
Mainz